Liječnički vjesnik, Vol. 134 No. 1-2, 2012.
Stručni rad
CLINICAL RECOMMENDATIONS FOR TREATING AND MONITORING PATIENTS WITH RENAL CANCER
Marija Petković
Eduard Vrdoljak
Ira Pavlović Ružić
Borislav Belev
Tomislav Omrčen
Dubravka Ledina
Rudolf Tomek
Boris Ružić
Marijan Šitum
Ante Buća
Valdi Pešutić Pisac
Sažetak
Clear cell renal carcinoma is the most common kidney cancer. It is generally asymptomatic. A small percentage of patients present with hematuria, flank pain and abdominal mass. It is usually detected accidentally during radiologic examination. The diagnosis of kidney cancer is confirmed by pathohistological findings after completion of the diagnostic process. The decision about treatment is made based on clinical assessment of disease stage and other risk factors. Depending on that, treatment options include surgery, and considering high resistance of kidney cancer on chemotherapy and hormone therapy, use of targeted therapies (immunotherapy, tyrosine kinase inhibitors) and palliative radiotherapy. The following text presents the clinical guidelines in order to standardize procedures and criteria for the diagnosis, management, treatment and monitoring of patients with kidney cancer in the Republic of Croatia.
Ključne riječi
Carcinoma, renal cell – diagnosis, pathology, therapy; Kidney neoplasms – diagnosis, pathology, therapy; Practice guidelines as topic; Croatia
Hrčak ID:
172382
URI
Datum izdavanja:
29.2.2012.
Posjeta: 1.234 *